Two Sigma Advisers LP Reduces Stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Two Sigma Advisers LP decreased its holdings in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 4.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,600 shares of the company’s stock after selling 1,200 shares during the quarter. Two Sigma Advisers LP owned approximately 0.15% of Nature’s Sunshine Products worth $405,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NATR. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Nature’s Sunshine Products in the fourth quarter valued at approximately $314,000. Northern Trust Corp boosted its holdings in shares of Nature’s Sunshine Products by 2.7% in the 4th quarter. Northern Trust Corp now owns 119,005 shares of the company’s stock valued at $1,745,000 after buying an additional 3,174 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Nature’s Sunshine Products in the 4th quarter valued at $200,000. BNP Paribas Financial Markets raised its stake in Nature’s Sunshine Products by 346.9% during the 4th quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company’s stock worth $172,000 after acquiring an additional 9,097 shares in the last quarter. Finally, Amundi acquired a new stake in Nature’s Sunshine Products during the 4th quarter worth $63,000. 79.40% of the stock is owned by institutional investors and hedge funds.

Nature’s Sunshine Products Trading Down 1.8%

Shares of NASDAQ NATR opened at $14.41 on Thursday. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $18.06. The stock has a 50 day moving average of $13.03 and a two-hundred day moving average of $14.09. The stock has a market cap of $264.44 million, a P/E ratio of 16.38 and a beta of 1.10.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its earnings results on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.09. Nature’s Sunshine Products had a net margin of 3.81% and a return on equity of 11.08%. The business had revenue of $113.25 million for the quarter, compared to analysts’ expectations of $109.39 million.

Analysts Set New Price Targets

Separately, DA Davidson restated a “buy” rating and issued a $19.00 price objective on shares of Nature’s Sunshine Products in a research note on Tuesday.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.